Healthcare >> CEO Interviews >> June 2, 2002

Steven Bernitz – Organogenesis Inc (org)

TWST: Can we start off with an update of Organogenesis? What has gone on

over the past years that investors should focus on?

Mr. Bernitz: I think the main thing has been the company's shift